HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bushel Of Goli Apple Cider Vinegar Gummy Claims Crushed In NAD Review Of Pharmavite Challenge

Executive Summary

Pharmavite challenged express and implied claims Goli used online and in social media promoting its product's benefits for weight loss, appetite satiety and craving, heart health, immune, energy, complexion, digestion, bloating, indigestion, heartburn and detoxification.

You may also be interested in...



Wellness Product Launches: Hydrant Caffeine Sports Drink, Swisse Nutrition In A Tube, More

Kinin launches CBD + Aromatherapy pods; WeHo mixes CBD in cocktail chaser, mixer; Hydrant adds caffeine to sports drink; Victory Nutrition offers customized RestoreGen supplements; Swisse offers Jelly nutrition in a tube; Stunn supplements for AM, PM beauty; Goli first with apple cider gummy; and Social Cannabinoids CBD drops launch.

J&J’s Consumer Health Product Sales Slump In Comparison A Year After COVID-19 Stockpiling

Worldwide consumer health sales in January-March period were down 3.3% to $3.5bn with results off 7.4% to $1.6bn in the US and up 0.5% to $1.9bn internationally. However, excluding “COVID-19 comparison” in the year-ago period, the consumer health segment grew low-single-digits.

US House Co-signs Banking For Hemp Industry

House passes “SAFE Banking” Act sponsored by Rep. Ed Perlmutter to allow cannabis- and hemp-related businesses in states with some form of legalized marijuana to access financial services by creating protections for those institutions. Sen. Jeff Merkley introduced the same legislation in March.

Topics

UsernamePublicRestriction

Register

RS151125

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel